There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for Spectrum Pharmaceuticals Inc. (SPPI) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.01, or 2.00%, to $0.51. The Spectrum Pharmaceuticals Inc. has recorded 7,764 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted Spectrum Pharmaceuticals Announces Management Changes.
As a NASDAQ listed company, SPPI falls under the Healthcare sector while operating within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $0.50 and fluctuated between $0.5399 as its day high and $0.4750 as its day low. The current market capitalization of Spectrum Pharmaceuticals Inc. is $92.74M. A total of 1.21 million shares were traded on the day, compared to an average of 1.91M shares.
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, SPPI has seen 2 BUY and 0 SELL insider trades, representing the acquisition of 100,000 and the disposition of 0 shares. Over the last 12 months, there were 13 BUYs and 24 SELLs from insiders. Insiders purchased 1,632,811 shares during that period but sold 321,833.
In the most recent transaction, Riga Thomas J sold 23,929 shares of SPPI for 0.38 per share on Jan 03. After the transaction, the CEO & President now owns 1,189,411 company shares. In a previous transaction on Nov 30, Vacirca Jeff L bought 50,000 shares at 0.45 per share. SPPI shares that Director owns now total 270,244.
Among the insiders who sold shares, LEBEL FRANCOIS disposed of 6,667 shares on Jun 23 at a per-share price of $0.84. This resulted in the Chief Medical Officer holding 644,790 shares of SPPI after the transaction. In another insider transaction, LEBEL FRANCOIS sold 6,096 shares at $0.81 per share on Jun 22. Company shares held by the Chief Medical Officer now total 651,457.
Investors prefer companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook. SPPI’s most recent ex-dividend date was 12/18/2012 when it declared a $0.15 quarterly dividend that was paid in cash on 12/28/2012.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for SPPI in the last 3 months, the mean price target is $3.13 with high estimates of $4.00 and low estimates of $1.00. In terms of 52-week highs and lows, SPPI has a high of $1.57 and a low of $0.31.
As of this writing, SPPI has an earnings estimate of -$0.15 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of -$0.14 per share and a lower estimate of -$0.16. The company reported an EPS of -$0.09 in the last quarter, which was 52.60% higher than expectations of -$0.19.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 4 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SPPI is Buy with a score of 4.00. A total of 3 analysts rated the stock as Buy while 0 rated it as Overweight while 1 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.